- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
AMO offers new ultrasound technology for phaco system
Santa Ana, CA?Abbott Medical Optics (AMO) announced that enhanced ultrasound technology (Ellips FX Transversal Ultrasound Technology) is available for its phacoemulsification system (WhiteStar Signature).
Santa Ana, CA
- Abbott Medical Optics (AMO) announced that enhanced ultrasound technology (Ellips FX Transversal Ultrasound Technology) is available for its phacoemulsification system (WhiteStar Signature).
Refined features over the company’s original ultrasound technology (Ellips) include higher frequency cutting performance; larger zone of tissue removal; improved efficiency for removal of hard or soft cataracts, working with preferred cataract surgery technique or tip style; and controlled utilization of power required for lens extraction, as well as unique movement of the tip minimizing the potential for clogging and contributing to overall stability of the chamber.
AMO said it has begun shipping the new ultrasound technology to surgeons throughout the United States.
